Vicasol, 1% 1 ml 10 pcs

Hepatitis, Bleeding, Liver cirrhosis, Menstrual disordersHemorrhagic syndrome associated with hypoprothrombinemia; hypovitaminosis K (including In gynecology as a part of complex treatment of dysfunctional uterine bleedings, not connected with organic pathology, at menorrhagia. As a specific antagonist for bleeding associated with taking indirect anticoagulants. III trimester of pregnancy (for prevention of bleeding in newborns).

Indications

Hemorrhagic syndrome associated with hypoprothrombinemia; hypovitaminosis K (including with obstructive jaundice, hepatitis, liver cirrhosis, prolonged diarrhea); hemorrhagic disease of newborns; bleeding after wounds, trauma and surgery; in gynecology as part of the complex treatment of dysfunctional uterine bleeding not associated with organic pathology, with menorrhagia. As a specific antagonist for bleeding associated with taking indirect anticoagulants. III trimester of pregnancy (to prevent bleeding in newborns).

Pharmacological effect

Antihemorrhagic agent.

Special instructions

For diseases leading to impaired bile outflow, parenteral administration is recommended. For hemophilia and Werlhof’s disease, menadione is ineffective.

Active ingredient

Menadione sodium bisulfite

Composition

1 ml contains:

Contraindications

Increased blood clotting, thromboembolism, increased sensitivity to menadione.

Side Effects

Allergic reactions: skin rash, itching, erythema, urticaria, bronchospasm.

From the blood coagulation system: hemolytic disease of newborns.

Interaction

When used simultaneously with oral anticoagulants, the anticoagulant effect may be reduced.

Storage conditions

In a place protected from light at a temperature not exceeding 25 ° C.

Do not freeze.

Keep out of the reach of children.

Shelf life

3 years.

Manufacturer

Dalkhimfarm, Russia